Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cepeda

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Journal of Neuroscience Research|July 30, 2019
Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observationsCarlos Cepeda, Katerina D Oikonomou, Damian Cummings, et al.
Epilepsia Open|December 20, 2018
Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologiesCarlos Cepeda, Simon Levinson, Vannah-Wila Yazon, et al.
Neural Computation|June 13, 2018
A Basic Phase Diagram of Neuronal DynamicsWenyuan Li, Igor V Ovchinnikov, Honglin Chen, et al.
Journal of Neuroscience Research|October 27, 2004
Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNFCarlos Cepeda, Amaal J Starling, Nanping Wu, et al.
CNS Neuroscience & Therapeutics|March 8, 2018
Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findingsSandra M Holley, Talia Kamdjou, Jack C Reidling, et al.
Eneuro|July 24, 2015
Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's DiseaseSandra M Holley, Prasad R Joshi, Anna Parievsky, et al.
Journal of Neuropathology and Experimental Neurology|June 6, 2007
Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasiaVéronique M André, Nanping Wu, Irene Yamazaki, et al.
Neuron|May 26, 2004
Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminalsNigel S Bamford, Hui Zhang, Yvonne Schmitz, et al.
Frontiers in Neurology|April 21, 2017
Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?Michael K Leuchter, Elissa J Donzis, Carlos Cepeda, et al.
Frontiers in Systems Neuroscience|May 28, 2011
Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatumEmily L Jocoy, Véronique M André, Damian M Cummings, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Journal of Neuroscience Research|July 30, 2019
Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observationsCarlos Cepeda, Katerina D Oikonomou, Damian Cummings, et al.
Epilepsia Open|December 20, 2018
Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non-mTOR-mediated etiologiesCarlos Cepeda, Simon Levinson, Vannah-Wila Yazon, et al.
Neural Computation|June 13, 2018
A Basic Phase Diagram of Neuronal DynamicsWenyuan Li, Igor V Ovchinnikov, Honglin Chen, et al.
Journal of Neuroscience Research|October 27, 2004
Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNFCarlos Cepeda, Amaal J Starling, Nanping Wu, et al.
CNS Neuroscience & Therapeutics|March 8, 2018
Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findingsSandra M Holley, Talia Kamdjou, Jack C Reidling, et al.
Eneuro|July 24, 2015
Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's DiseaseSandra M Holley, Prasad R Joshi, Anna Parievsky, et al.
Journal of Neuropathology and Experimental Neurology|June 6, 2007
Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasiaVéronique M André, Nanping Wu, Irene Yamazaki, et al.
Neuron|May 26, 2004
Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminalsNigel S Bamford, Hui Zhang, Yvonne Schmitz, et al.
Frontiers in Neurology|April 21, 2017
Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?Michael K Leuchter, Elissa J Donzis, Carlos Cepeda, et al.
Frontiers in Systems Neuroscience|May 28, 2011
Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatumEmily L Jocoy, Véronique M André, Damian M Cummings, et al.
Pageof 15